|
·ÖÀർº½ |
 |
|
|
|
ÃÀ¹ú¼ÆËã»ú»¯ÁÙ´²Êµ¼ùÖ¸ÄÏÑо¿½øÕ¹£¶þ´ÎÐ޸ģºÎÓêÉú |
|
×ÊÔ´´óС£º205.88 KB |
×ÊÔ´ÀàÐÍ£ºÎĵµ |
ÏÂÔØ»ý·Ö£º 0 |
|
|
|
×ÊÔ´½éÉÜ |
|
ÃÀ¹ú¼ÆËã»ú»¯ÁÙ´²Êµ¼ùÖ¸ÄÏÑо¿½øÕ¹
ºÎÓêÉú ËïºêÓî
±±¾©Ò×·É»ªÍ¨¿Æ¼¼¿ª·¢ÓÐÏÞ¹«Ë¾
±±¾©´óѧÈËÃñҽԺҽѧÐÅÏ¢ÖÐÐÄ
ÕªÒª£ºÁÙ´²Êµ¼ùÖ¸ÄϵļÆËã»ú»¯×÷Ϊһ¸öÐÂÐËѧ¿Æ£¬ÒòÆä¼«´óµØÀ©Õ¹ÁËÖ¸ÄϵÄÓ¦ÓÃÁìÓòºÍ´´ÔìÁËÓë¸÷ÖÖÁÙ´²¼ÆËã»úϵͳµÄ½áºÏ¿ÉÄÜ£¬Ô½À´Ô½Êܵ½¸÷¹úҽѧ½çµÄÖØÊÓ¡£±¾ÎÄÈ«Ãæ½éÉÜÁËÁÙ´²Êµ¼ùÖ¸Äϵķ¢Õ¹ºÍÄÚÈÝ¡¢½á¹¹£¬·ÖÎöÁËÁÙ´²Êµ¼ùÖ¸ÄϵÄÌØÕ÷£¬¶ÔÖ¸ÄϼÆËã»ú»¯µÄÖØÒªÐÔ½øÐÐÁËÂÛÖ¤£¬²¢¶ÔÃÀ¹úÔÚÕâһѧ¿Æ·¢Õ¹µÄÏÖ×´×öÁ˸ÅÊö£¬×ܽá³öÁËÖ¸ÄϼÆËã»ú»¯µÄÁ½ÖÖºê¹Û˼·£¬²¢ÒÔGEMºÍGLIFÁ½¸öÏîÄ¿×÷¶Ô±È£¬¶ÔÁ½ÖÖ½¨Ä£·½·¨½øÐÐÁËÏêϸ·ÖÎö£¬×îºó½øÐÐÁËÌÖÂÛ¡£
Abstract: As a rising research field, Computerized Clinical Practical Guideline (CPG) which broadly extends the application of CPG and enable the connection with Clinical Information System become more and more important. This paper introduces CPG¡¯s development¡¢structure and feature, gives the reason for computerizing CPG, and summarizes the relative research status in America in recent years , concludes two methods of CCPG from several projects, and examples the methods with GEM and GLIF. Discussion is given at last.
¹Ø¼ü´Ê£º ÁÙ´²Êµ¼ùÖ¸ÄÏ£»¼ÆËã»ú»¯£»GEM£»GLIF£»Ö¸ÄϽ¨Ä££»
Keywords: Clinical Practical Guideline; Computerization; GEM; GLIF£»Guideline Modeling£»
Ò»£®ÁÙ´²Êµ¼ùÖ¸ÄϽéÉÜ
1£®Ö¸Äϵ͍Òå¡¢ÄÚÈÝ¡¢½á¹¹
°´ÕÕ1990ÄêÃÀ¹úҽѧÑо¿Ëù¸øÁÙ´²Êµ¼ùÖ¸ÄÏ£¨ÒÔϼò³ÆÖ¸ÄÏ£©ËùÏµĶ¨Ò壬ָÄÏÊÇϵͳ¿ª·¢µÄ¶à×éÁÙ´²Ö¸µ¼Òâ¼û£¬ÓÃÓÚ°ïÖúÒ½ÉúºÍ²¡ÈËÕë¶ÔÌØ¶¨µÄÁÙ´²ÎÊÌâ×ö³öÇ¡µ±µÄ´¦Àí¡¢Ñ¡Ôñ£¬¾ö²ßÊÊÒ˵ÄÎÀÉú±£½¡·þÎñ[1]¡£
ÔÚ¹ýÈ¥µÄÊ®Äê¼ä£¬ÊÀ½ç¸÷¹ú·×·×¿ªÕ¹Ö¸ÄϵĹæÔòÖÆ¶¨ºÍ¾ßÌå±àд¹¤×÷£¬ÃÀ¹úÎÀÉú²¿³ÉÁ¢Á˱£½¡Ñо¿ºÍÖÊÁ¿¾Ö(Agency for Healthcare Research and Quality ,AHRQ),ÿÄêͶÈëÊýÒÚÃÀÔªÍÆ¶¯ÁÙ´²Êµ¼ùÖ¸ÄϵÄÖÆ¶¨£»Å·ÖÞ¹ú¼ÒÖÆ¶¨Ö¸ÄϵÄËٶȸüÊǾªÈË: Èç·¨¹ú¹«²¼Á˰ÙÓà¸öÖ¸ÄÏ,±±Å·µÄŲÍþ´Ó1978 ÄêÖÁ½ñ·¢²¼ÁË70 ¸öÖ¸ÄÏ·ÒÀ¼´Ó1989 ÄêÖÁ½ñ¹²¹«²¼ÁË700 Óà¸öÖ¸ÄÏ[2]¡£
National Guideline Clearinghouse(NGC)ÊÇÃÀ¹úÎÀÉú±£½¡Ñо¿ºÍÖÊÁ¿¾Ö½¨Á¢µÄ£¬ÃæÏò´óÖÚµÄÃâ·ÑÁÙ´²Êµ¼ùÖ¸ÄÏÊý¾Ý¿â, ½ØÖÁ06Äê5Ô£¬ÆäÏÂÒÑ´æÓÐ1900ÓàÆªÖ¸ÄÏÈ«ÎÄ[3]¡£°´ÕÕÄÚÈÝÏêϸ³Ì¶È²»Í¬£¬NGC¿âÖеÄÖ¸Ä϶¼¾ß±¸Á½¸ö°æ±¾£º¸ÅÒªÐÔÖ¸ÄÏ(Brief Summary)ºÍÍêÕûÖ¸ÄÏ(Complete Summary)£¬ÏÖÒÔһƪÍêÕûÖ¸ÄÏΪÀý£¬À´½éÉÜÖ¸ÄϵĽṹºÍÄÚÈÝ[4]¡£
ÔÚÖ¸ÄϵĿªÍ·£¬»áÏȸø³öÒÔÏÂÄÚÈÝ£º
Ö¸ÄϱêÌâ(GUIDELINE TITLE)£º¸ø³öÖ¸ÄϵÄÎÄÕ±êÌâ¡£
ÊéÄ¿À´Ô´(BIBLIOGRAPHIC SOURCE(S))£º×«Ð´¸ÃÖ¸ÄϹý³ÌÖÐÒýÓõ½µÄÊý¾ÝµÄÀ´Ô´¡£
Ö¸ÄϵÄ״̬(GUIDELINE STATUS)£º¸ø³ö¸ÃÖ¸Äϵ±Ç°µÄ°æ±¾Çé¿ö¡£ÊÓÇé¿ö²»Í¬£¬×´Ì¬Ò»°ã·ÖΪÏÂÃæ¼¸ÖÖÇé¿ö£º1 ¸ÃÖ¸ÄÏΪµÚÒ»¸å£¬²¢ÇÒÒѾ¹ýÉóºË£¬ÊÇ¿ÉÓð汾¡£2 ¸ÃÖ¸ÄϸüÐÂÁË֮ǰµÄ¾É°æ±¾Í¬ÃûÖ¸ÄÏ¡£Õâʱ»áÏêϸÁгö¾É°æ±¾µÄ׫д»ú¹¹£¬¼°¿¯Ôؾɰ汾ָÄϵĿ¯ÎïµÄ¿¯Ãû£¬³ö°æÊ±¼ä¼°ËùÔÚÒ³Âë¡£
½ÓÏÂÀ´ÊÇÕýÎIJ¿·Ö£º
A. ÁìÓò (SCOPE)
A.1. ¼²²¡/×´¿ö£ºÖ¸ÄÏËù¹Ø×¢µÄ¼²²¡Àà±ð¡¢ÁÙ´²Çé¾°
A.2. Ö¸ÄÏÖÖÀࣺ°´ÕÕÖ¸ÄÏËùÆðµÄ¹¦ÄÜÀ´·Ö£¬ÓÐÒÔÏÂÀà±ð£ºÆÀ¹À¡¢¹ÜÀí¡¢ÐÉÌ£¬Ô¤·À¡¢·çÏÕÆÀ¹À¡¢¼¼ÊõÆÀ¹À¡¢ÖÎÁÆ¡¢Õï¶ÏµÈ¡£Ò»ÆªÖ¸ÄϿɸ´Ñ¡ÒÔÉÏÖÖÀà¡£
A.3. ÁÙ´²×¨Òµ£ºÖ¸ÄÏÄÚÈÝËùÉæ¼°µÄÒ½ÁÆÑ§¿Æ¡£
A.4. Õë¶ÔµÄÓû§£º¸ÃÖ¸Äϱ»±àдÒԱ㹩ÄÄЩÈËÀ´ÔĶÁ¡£
A.5. Ö¸ÄϵÄÄ¿±ê£ºÍ¨¹ýÖ¸ÄϵÄŬÁ¦£¬ÒâÓûʵÏÖµÄÄ¿±ê£¬´ï³ÉµÄ½á¹û¡£
A.6. Ä¿±êÈËȺ£ºÄÄЩ²¡»¼ÊÇÊôÓÚ¸ÃÖ¸ÄÏËù¹Ø×¢µÄ£¬ËùÊÊÓõġ£
A.7. Éæ¼°µÄ¸ÉÔ¤ºÍ·½°¸
A.8. Ö÷Òª³É¹û
B. ·½·¨Ñ§ (METHODOLOGY)
B.1. ÓÃÓڲɼ¯¡¢Ñ¡ÔñÖ¤¾ÝµÄ·½·¨
B.2. ¶Ô²É¼¯¡¢Ñ¡ÔñÖ¤¾ÝµÄ·½·¨µÄÃèÊö
B.3. Ô´ÎĵµµÄÊýÁ¿
B.4. ÓÃÓÚÆÀ¹ÀÖ¤¾ÝµÄÖÊÁ¿ºÍÇ¿¶ÈµÄ·½·¨
B.5. Ö¤¾ÝÇ¿¶È·Ö¼¶Ìåϵ
B.6. ÓÃÓÚ·ÖÎöÖ¤¾ÝµÄ·½·¨
B.7. ¶Ô·ÖÎöÖ¤¾ÝµÄ·½·¨µÄÃèÊö
B.8. ½¨ÒéµÄ±íÊö·½Ê½
B.9. ¶Ô½¨ÒéµÄ±íÊö·½Ê½µÄÃèÊö
B.10. ½¨ÒéÇ¿¶È·Ö¼¶Ìåϵ
B.11. ´ú¼Û·ÖÎö
B.12. Ö¸ÄÏУÑé·½·¨
B.13. ¶ÔÖ¸ÄÏУÑé·½·¨µÄÃèÊö
C. ½¨Òé (Recommendation)
C.1. Ö÷Òª½¨Òé
Õⲿ·ÖÊÇÖ¸ÄϵĺËÐÄËùÔÚ£¬Ö÷Òª½¨ÒéÖ¼ÔÚ¸ø³ö£ºÔÚ¸ÃÖ¸ÄÏËù̽ÌÖµÄÒ½Áƹý³ÌÁìÓòÄڵģ¬Õë¶Ô¾ßÌåÊÖÊõÇé¾³µÄ´¦Àí¡¢¼à»¤·½·¨µÄ½¨Ò顣ͬʱ»áÔÚ½¨ÒéµÄĩβ¸½¼ÓÉϸÃÖ¸ÄÏÐÐʹµÄҽѧ֤¾Ý·Ö¼¶±ê×¼£¬ÕâÑù¾Í¿ÉÒÔ¶ÔÿһÌõ¾ßÌ彨Ò鏸³öÒ»¸ö¶ÔÓ¦Óڸ÷ּ¶±ê×¼µÄ¼¶±ð£¬Ã÷È·¸Ã½¨ÒéµÄÀíÂÛÓÐЧÐÔ¡£
ҽѧ֤¾Ý·Ö¼¶±ê×¼: Ñ֤ҽѧǿµ÷Ö¤¾Ý,ÒªÇóÁÙ´²Ñо¿ÕߺÍÓ¦ÓÃÕß¾¡¿ÉÄÜÌṩºÍÓ¦Óõ±Ç°×î¿É¿¿µÄÁÙ´²Ñо¿Ö¤¾Ý¡£Ö¸ÄϵÄҽѧ֤¾Ý·Ö¼¶±ê×¼±Ë´Ë¼äÂÔÓв»Í¬£¬µ«ÊÇÕûÌåÉϲî±ð²»´ó£¬ÏÂÃæ¸ø³öÒ»¸öʾ·¶Ìåϵ£º
Ò»¼¶£º°´ÕÕËùÕë¶Ô¼²ÖÖµÄÌØ¶¨ÁÆ·¨ÊÕ¼¯ËùÓÐÖÊÁ¿¿É¿¿µÄËæ»ú¶ÔÕÕÊÔÑéºóËù×÷µÄϵͳÆÀ¼Û»òMeta-·ÖÎö¡£¶þ¼¶£ºµ¥¸öµÄÑù±¾Á¿×ã¹»µÄËæ»ú¶ÔÕÕÊÔÑé½á¹û¡£Èý¼¶£ºÉèÓжÔÕÕ×鵫δÓÃËæ»ú·½·¨·Ö×éµÄÑо¿¡£Ëļ¶£ºÎÞ¶ÔÕÕµÄϵÁв¡Àý¹Û²ì¡£Îå¼¶£º×¨¼ÒÒâ¼û¡£
C.2. ÁÙ´²Ëã·¨
ÕâÀï¿ÉÀí½âΪÊÔͼ¸ø³öÒ»¸öÐÎʽ»¯µÄÁÙ´²½â¾ö·½°¸£¬Ä¿Ç°¾ø´ó¶àÊýÖ¸ÄÏÈÔÈ»ÎÞ·¨Ìṩ¶ÔÓ¦ÓÚÖ¸ÄÏÄÚÈݵÄÈ«²¿»òÕß²¿·Ö´¦Àí·½°¸µÄÐÎʽ»¯±íÊö¡£¶øÄÇЩ¸ö±ðÄܹ»Ìṩ³öËã·¨µÄÖ¸ÄÏ£¬´ó¶àÊýÊÇÒÔÊ÷Ðͽṹ·ÖÖ§µÄÁ÷³ÌͼÀ´±íÊö¸ÃËã·¨¡£
D. ÓÃÓÚÖ§³Ö½¨ÒéµÄÖ¤¾Ý (EVIDENCE SUPPORTING THE RECOMMENDATIONS)
D.1. ²Î¿¼²ÄÁÏ£ºÖ¸ÄÏÖеĽ¨ÒéµÄÀíÂÛ»ù´¡£¬Êý¾ÝÀ´Ô´¡£
D.2. Ö¤¾ÝÀàÐÍÖ¤¾ÝµÄ·Ö¼¶ÐÅÏ¢¡£Ò»°ã²»ÔÚ´Ë´¦¸ø³ö£¬¶øÊÇÔÚ½¨Ò鲿·ÖµÄĩβÁгö
E. ʵÐн¨ÒéËù´øÀ´µÄÊÕÒæ/¸ºÐ§¹û (BENEFITS/HARMS OF IMPLEMENTING THE GUIDELINE RECOMMENDATIONS)
E.1. DZÔÚÊÕÒæ
E.2. DZÔÚ¸ºÐ§¹û
F. Ö¸ÄÏ×ʸñÉùÃ÷ (QUALIFYING STATEMENTS)
G. Ö¸ÄÏÖ´ÐÐ˵Ã÷ (IMPLEMENTATION OF THE GUIDELINE)
H. ¹úÁ¢½¡¿µ»¤ÀíҽѧԺÖÊÁ¿±¨¸æÖÖÀà (INSTITUTE OF MEDICINE (IOM) NATIONAL HEALTHCARE QUALITY REPORT CATEGORIES)
H.1. IOM »¤ÀíÐèÒª
H.2. IOMÁìÓò
I. ¼ø±ðÐÔÐÅÏ¢ºÍʵÓÃÐÔIDENTIFYING INFORMATION AND AVAILABILITY
J. Ãâ³ýÔðÈεÄÉùÃ÷ (DISCLAIMER)
2. Ö¸ÄϵÄÌØµã
ÁÙ´²Ö¸ÄÏÒÑÖ®ËùÒÔ³ÉΪÑ֤ҽѧºÍÁÙ´²Êµ¼ùµÄÖØÒª×é³É²¿·Ö£¬¹é¹¦ÓÚÆäÄÚÈݵĿÆÑ§ÐÔ¡¢×¼È·ÐÔ£¬¶øÕâºÍÑϸñµÄÖ¸ÄÏ¿ª·¢·½·¨ÊÇ·Ö²»¿ªµÄ¡£Ö¸ÄÏ¿ª·¢¹ý³ÌÓÐÒÔϼ¸¸öÌØµã£º
¿ª·¢ÖÜÆÚ³¤¨D¨DÿһƪָÄÏµÄÆ½¾ù¿ª·¢ÖÜÆÚÐèÒªÁ½ÄêµÄʱ¼ä¡£Ö¸ÄÏ¿ª·¢×éÓÉÓëËù±àдָÄÏÄÚÈݵÄÏà¹Ø¸÷ѧ¿ÆµÄר¼Ò×é³É¡£
ϵͳ¡¢ÑϽ÷µÄÎÄÏׯÀ¼Û·½·¨¨D¨Dһƪ¸ßÖÊÁ¿µÄÖ¸ÄÏ£¬ÔÚÆä±àдʱÐèÒªÊÕ¼¯¸ÃÁìÓòÄÚËùÓÐÒÑ·¢±íµÄÏà¹ØÁÙ´²Ñо¿³É¹û£¬¶ÔÆä²ÉÓÃÑϸñµÄÆÀ¼ÛÎÄÏ×µÄÔÔòºÍ·½·¨£¨ÈçMeta-·ÖÎö£©£¬´ÓÖÐɸѡ³ö·ûºÏÖÊÁ¿±ê×¼µÄÎÄÏ×£¬½øÐж¨ÐÔ»ò¶¨Á¿ºÏ³É£¬×îºóµÃ³ö×ۺϿɿ¿µÄ½áÂÛ¡£
¿Í¹ÛÏêϸµÄÖ¤¾Ý·Ö¼¶¨D¨DÖ¸ÄÏÖеÄÿһ¸öÁÙ´²½¨Ò飬¶¼À´Ô´ÓÚ´óÁ¿µÄÁÙ´²¿ÆÑÐÒÀ¾Ý¡£Ä¿Ç°¹ú¼ÊÉÏÆÕ±é°´ÕÕÁÙ´²ÒÀ¾ÝµÄˮƽ(Level)¡¢Ñо¿ÖÊÁ¿(Quality)¿ØÖƵij̶ȡ¢Ö¤¾Ý×ÔÉíµÄ¿É¿¿ÐÔ¼°ÁÆÐ§µÄÇ¿¶È(Strength)Ëĸö·½Ã棬ÔÚ±àдָÄÏʱ¶ÔÆäÖеÄÁÙ´²½¨Òé½øÐÐÁËÖ¤¾Ý·Ö¼¶[5]¡£±í1ÊÇÒ»¸ö¼¶±ð±ê×¼µÄʵÀý¡£
Ö¤¾Ý¼¶±ð ¼¶±ðÏêϸÐÅÏ¢
Ia ¶Ô¶àÏîËæ»ú¶ÔÕÕÊÔÑé½øÐÐMeta-·ÖÎö¶øµÃµ½µÄÖ¤¾Ý
Ib ÖÁÉÙ¸ù¾ÝÒ»ÏîËæ»ú¶ÔÕÕÊÔÑé
IIa ÖÁÉÙ¸ù¾ÝÒ»ÏîÑϸñÉè¼ÆµÄÎ´Ëæ»ú»¯µÄ¶ÔÕÕÊÔÑé
IIb ÖÁÉÙ¸ù¾ÝÒ»ÏîÆäËûÀàÐ͵ÄÑϸñÉè¼ÆµÄ×¼ÊÔÑéÑо¿
III ¸ù¾ÝһЩÑϸñÉè¼ÆµÄ·ÇÊÔÑéÐÔµÄÑо¿£¬Èç±È½ÏÑо¿
¡¢Ïà¹ØÑо¿»ò¸ö°¸±¨µÀ
IV ¸ù¾Ýר¼ÒίԱ»á±¨¸æ¡¢Òâ¼û£¬ºÍ/»òÁîÈË×ðÖØµÄר¼Ò
¡¢È¨ÍþÃǵÄÁÙ´²¾Ñé
±í1 Ö¤¾Ý·Ö¼¶±ê×¼
¾ßÌåµÄ½¨Òé·Ö¼¶¨D¨DÔÚÁÙ´²Ö¤¾Ý·Ö¼¶µÄ»ù´¡ÉÏ£¬Ïà¶ÔÓ¦µÄ£¬Ã¿Ò»ÌõÁÙ´²½¨ÒéÒ²Óзּ¶±ê×¼£¬Ïê¼û±í2¡£
½¨Òé·Ö¼¶ ·Ö¼¶ÏêϸÐÅÏ¢
Ò»¼¶ °´ÕÕÌØ¶¨¼²ÖÖµÄÌØ¶¨ÁÆ·¨ÊÕ¼¯ËùÓÐÖÊÁ¿¿É¿¿µÄËæ»ú¶ÔÕÕÊÔÑé
¶þ¼¶ µ¥¸öµÄÑù±¾Á¿×ã¹»µÄËæ»ú¶ÔÕÕÊÔÑé½á¹û¡£
Èý¼¶ ÓжÔÕÕ×鵫δÓÃËæ»ú·½·¨·Ö×éµÄÑо¿¡£
Ëļ¶ ÎÞ¶ÔÕÕµÄϵÁв¡Àý¹Û²ì
Îå¼¶ ר¼ÒÒâ¼û
±í2 ½¨Òé·Ö¼¶±ê×¼
ÁÙ´²Êµ¼ùÖ¸ÄϽ«´óÁ¿µÄ·ûºÏͳ¼ÆÑ§±ê×¼µÄҽѧÊÔÑé½á¹û³éÏó³ÉΪ·½±ãºÍÈÝÒ×ʹÓõÄÒ»ÖÖÐÎʽ£¬ÎªÁÙ´²¹¤×÷ÌṩÈÎÒâºÍ¿É¿¿µÄ¾ö²ßÐÅÏ¢£¬Ê¹ÁÙ´²¾ö²ß¸ü¼Ó¸ßЧ׼ȷ£¬²¢·ûºÏÂ×ÀíºÍ·¨ÂɵÄÒªÇó[6]¡£ÆäÖØÒªÒâÒåÔÚÓÚ£¬×«Ð´³É׼ȷÑϽ÷µÄÎÄÕ£¬ÒÔʹҽ»¤ÈËÔ±»ñÈ¡¡¢ÔĶÁÁÙ´²¿ÆÑнá¹û±äµÃ¸üΪ±ãÀû£¬Ñ֤ҽѧ֤¾ÝÄܹ»¼òµ¥·½±ãµØ±»Ó¦Óõ½ÁÙ´²¹¤×÷ÖС£
¶þ¡¢ÁÙ´²Êµ¼ùÖ¸ÄϵļÆËã»ú»¯
1. ÒâÒå
¾¡¹ÜÖ¸ÄϵÄÄÚÈÝÒòÆäȨÍþÐÔ¡¢¿ÆÑ§ÐÔ¶øµÃµ½ÊÀ½ç¸÷¹úҽѧ½çµÄÒ»ÖÂÈϿɣ¬²¢×÷Ϊָµ¼Ò½ÁÆÑо¿ºÍʵ¼ùµÄÖØÒªÊֶΣ¬µ«Êǵ½Ä¿Ç°ÎªÖ¹£¬Ö¸ÄÏÒ»Ö±ÊÇÒÔÎı¾¸ñʽ·¢²¼ºÍʹÓõģ¬Ò²¾ÍÊÇ˵£¬Ö¸Äϵıí´ïÐÎʽÊÇÈËÀàÓÃÓÚÃèÊö¿Í¹ÛÊÀ½çµÄ×îÔʼÓÐЧ |
|
ÏÂÔØµØÖ· |
|
|
|
|
|